| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.97B | 18.40B | 17.18B | 15.74B | 16.42B | 15.10B |
| Gross Profit | 4.16B | 3.95B | 3.30B | 2.30B | 2.79B | 2.79B |
| EBITDA | 3.44B | 3.28B | 2.74B | 2.02B | 2.32B | 2.30B |
| Net Income | 1.13B | 1.07B | 675.33M | 148.51M | 324.00M | 345.08M |
Balance Sheet | ||||||
| Total Assets | 36.61B | 36.66B | 34.55B | 31.29B | 31.78B | 36.59B |
| Cash, Cash Equivalents and Short-Term Investments | 2.52B | 2.55B | 2.38B | 2.58B | 2.49B | 2.72B |
| Total Debt | 14.98B | 13.95B | 12.41B | 11.34B | 11.52B | 16.36B |
| Total Liabilities | 19.66B | 19.58B | 18.32B | 15.89B | 16.25B | 21.17B |
| Stockholders Equity | 16.80B | 16.92B | 16.08B | 15.26B | 15.39B | 15.20B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.14B | -1.83B | 664.30M | 348.17M | 161.63M |
| Operating Cash Flow | 0.00 | 1.03B | 1.19B | 2.40B | 2.42B | 2.10B |
| Investing Cash Flow | 0.00 | -1.82B | -3.59B | -1.93B | -1.02B | -1.97B |
| Financing Cash Flow | 0.00 | 958.49M | 1.59B | -388.62M | -624.12M | -362.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥21.62B | 12.03 | ― | 4.36% | 1.52% | 16.04% | |
72 Outperform | ¥22.94B | 10.94 | ― | 3.29% | 29.97% | 19.33% | |
71 Outperform | ¥9.11B | 30.59 | ― | 5.03% | 12.91% | 59.12% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | ¥50.52B | 4.67 | ― | 2.38% | 33.64% | -0.28% | |
64 Neutral | ¥43.28B | 9.84 | ― | 0.45% | -8.33% | -36.89% | |
62 Neutral | ¥71.40B | 8.53 | ― | 2.89% | -3.09% | -35.66% |